BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25

• Press Releases

  SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER

  August 19, 2026

   · 

  7 min read
• Press Releases

  Solésence Reports Second Quarter 2026 Financial Results

  August 19, 2026

   · 

  8 min read
• Press Releases

  Ultragenyx Announces U.S. FDA Approval of GENGLYCOS™ Gene Therapy, the First-Ever FDA-Approved Treatment Designed to Treat the Underlying Cause of Glycogen Storage Disease Type Ia (GSDIa)

  August 19, 2026

   · 

  15 min read
• Press Releases

  Picard Medical Reports Second Quarter 2026 Financial Results

  August 19, 2026

   · 

  7 min read
• Press Releases

  Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program

  August 19, 2026

   · 

  7 min read
• Press Releases

  Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates

  August 19, 2026

   · 

  17 min read
• Press Releases

  Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline

  August 19, 2026

   · 

  17 min read